Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Vascudyne
company
About
Vascudyne is developing, manufacturing, and commercializing regenerative acellular in-vitro grown “allograft” tissue.
- 1 - 10
Highlights
Details
- Last Funding Type
- Grant
- Industries
- Biotechnology,Life Science,Medical
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Vascudyne is developing, manufacturing, and commercializing regenerative acellular in-vitro grown “allograft” tissue.Vascudyne is the world's leading center of excellence for developing and manufacturing engineered tissue. We provide our clients with world-class engineered tissue, unique engineered tissue-based device designs, manufacturing capabilities, technical expertise, and product development support.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Vascudyne has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
May 10, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 10, 2022 | Grant | — | 1 |
Regenerative Medicine Minnesota
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Vascudyne is funded by 1 investors.
Regenerative Medicine Minnesota
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Regenerative Medicine Minnesota
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
